Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials » (Galvano et al. J Bone Oncol 2019; 18:100252)

Publication date: Available online 28 April 2020Source: Journal of Bone OncologyAuthor(s): Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, Khalil Zaman, Olivier Lamy

https://www.sciencedirect.com/science/article/pii/S221213742030049X?dgcid=rss_sd...

Source: Journal of Bone Oncology - April 28, 2020 Category: Cancer & Oncology Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy

Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials&nbsp;» (Galvano et al. J Bone Oncol 2019; 18:100252)

Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials » (Galvano et al. J Bone Oncol 2019; 18:100252)